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Presenilins (PS) are critical components of the -secretase
complex that mediates cleavage of type I membrane proteins
including the -amyloid precursor protein to generate the amy-
loid -peptide. In addition, PS1 interacts with -catenin and
facilitates its metabolism. We demonstrate that phosphoryla-
tion of serines 353 and 357 by glycogen synthase kinase-3
(GSK3) induces a structural change of the hydrophilic loop of
PS1 that can also be mimicked by substitution of the phospho-
rylation sites by negatively charged amino acids in vitro and in
cultured cells. The structural change of PS1 reduces the interac-
tion with -catenin leading to decreased phosphorylation and
ubiquitination of -catenin. The decreased interaction of PS1
with -catenin leads to stabilization of -catenin thereby
increasing its nuclear signaling and the transcription of target
genes, including c-MYC. Consistent with increased expression
of c-myc, a PS1 mutant that mimics phosphorylated PS1
increased cell proliferation as compared with wild-type PS1.
These results indicate a regulatorymechanism inwhichGSK3-
mediated phosphorylation induces a structural change of the
hydrophilic loop of PS1 thereby negatively modulating the for-
mation of a ternary complex between -catenin, PS1, and
GSK3, which leads to stabilization of -catenin.
Mutations in the twoPRESENILIN (PS)2 genes are associated
with familial early onset Alzheimer disease. The genes encode
two homologues of polytropic membrane proteins that have
been shown to be critically involved in the generation of the
amyloid-peptide (1–3). PS1 andPS2 undergo endoproteolytic
processing within a hydrophilic loop region between trans-
membrane domains 6 and 7 resulting in N- and C-terminal
fragments (4–6). These assemble with nicastrin, aph-1, and
pen-2 to form a catalytically active -secretase complex that
catalyzes the intramembraneous cleavage of the-amyloid pre-
cursor protein and other type I membrane proteins (1, 7). PS
proteins have been localized to secretory and endocytic com-
partments including the endoplasmic reticulum, Golgi, and
endosomal/lysosomal compartments (2, 8, 9). In addition, PS
proteins are also located at the plasma membrane, where
-secretase cleavage of -amyloid precursor protein, Notch,
and cadherins can occur (10–13).
In addition to their function in membrane protein proteoly-
sis, PS proteins have been shown to be involved in the regula-
tion of apoptosis (5, 14–17). PS1 is also implicated in-catenin-
dependent signaling and directly binds via a large hydrophilic
loop domain to -catenin (18–20). -Catenin is a multifunc-
tional protein initially identified as a mediator of the cadherin-
dependent cell adhesion complex that links cadherins to the
actin cytoskeleton (21). In addition, a cytosolic pool of -cate-
nin acts in the canonicalWnt signaling pathway (22, 23). In the
absence of Wnt signal, free cytosolic -catenin undergoes
phosphorylation by casein kinase 1 and glycogen synthase
kinase-3 (GSK3) that associate in an axin-dependent multi-
protein complex (22, 24, 25). The phosphorylation of -catenin
targets it for ubiquitination anddegradation by the proteasome.
Activation of Wnt receptors leads to an accumulation of
-catenin in the cytosol by inhibition of its phosphorylation
(26). This pool of -catenin can translocate to the nucleus
where it associates withmembers of the T-cell factor/lymphoid
enhancer factor-1 (Tcf/Lef) family and regulates the expression
of target genes (23, 27).
Aberrant Wnt signaling has been shown to be associated
with tumorigenesis (22, 27, 28). In accordance with this, muta-
tions in-catenin and other proteins of theWnt signaling path-
way are the major cause of colon carcinomas (27, 28). In these
cells aberrantly high levels of -catenin are observed that lead
to increased nuclear signaling and the transcription of down-
stream genes. Of note, cells from PS1 knock-outmice also show
elevated levels of-catenin and increased expression of -cate-
nin target genes including CYCLIN D1 (29). Moreover, PS1
knock-out mice with targeted expression of PS1 in brain neu-
rons develop skin cancer (30). It has been shown that PS1 can
act as a scaffold protein, facilitating the phosphorylation of
-catenin by protein kinaseA andGSK3 (25). Previous studies
have demonstrated that GSK3 also phosphorylates PS1 in
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vitro and it has been proposed that the phosphorylation of PS1
increases binding of -catenin (31). However, a functional role
of this phosphorylation has not been demonstrated.
In this study we sought to investigate the function of PS1
phosphorylation by GSK3. We found that phosphorylation of
PS1 at the GSK3 phosphorylation sites induces a structural
change in the large hydrophilic loop domain of PS1 that could
be mimicked by introduction of negatively charged amino
acids. This conformational change strongly decreases the asso-
ciation of PS1 with -catenin leading to reduced phosphoryla-
tion and increased stabilization of-catenin thereby enhancing
its signaling to the nucleus.
EXPERIMENTAL PROCEDURES
cDNAs and Fusion Proteins—The phosphorylation site
mutants of PS1were generated by PCR techniques using appro-
priate oligonucleotides (sequences are available upon request).
The resulting PCR fragments were subcloned into the EcoRI/
XhoI restriction sites of pcDNA3.1 containing a Zeocin resist-
ance gene (Invitrogen). All constructswere verified by sequenc-
ing of both strands. The fusion proteins of maltose-binding
protein (MBP) and the hydrophilic loop domain of PS1 (amino
acids (aa) 263–407) have been described earlier (32). Briefly,
the coding region was amplified by PCR using the following
primers: 5-CCGAATTCTGTCCGAAAGGTCCA-3 and 5-
CCGGATCCCTAGGTTGTGTTCCAGTC-3. The resulting
fragment was cloned into the EcoRI/BamHI restriction site of
pMAL-c2 (New England Biolabs). Shorter versions of the
hydrophilic loop domains (aa 298–380) were generated using
the following primers: 5-CCGGAATTCATGGCAGAAG-
GAG-3, 5-ACGCGTCGACCTATTTTACTCCCC-3. The
resulting fragments were cloned into the EcoRI/SalI restriction
sites of pMAL-c2. A glutathione S-transferase (GST) fusion
protein with -catenin (aa 134–668) containing the binding
region for PS1 was generated using the following primers: 5-
CGCGGATCCACCATGCAGTTGTCAATTTGATTAAC-
3, 5-CCGCTCGAGTTACTGTGGCTTGTCCTCAGACA-
3. The resulting fragments were cloned into the BamHI/XhoI
restriction sites of pGEX-5.1 (GE Healthcare). For the GST
control protein the pGEX-5.1 vector was transformed. All
fusion proteins were expressed in Escherichia coli DH5. MBP
and GST fusion proteins were purified on amylose- or GSH-
resin, respectively, according to the supplier’s instructions.
Antibodies—Polyclonal antibody 3109 was raised against
the hydrophilic loop domain (aa 263–407) of PS1. The MBP
fusion proteins were purified as described above and inocu-
lated into rabbits (Eurogentec). The monoclonal antibody
against PS1 hydrophilic loop, APS18, has been described
previously (6). Anti-PS2-GST antibody (2972) was described
previously (33). Antibodies against -catenin (C2206) and
phospho-specific anti-pSer33,37--catenin (C4231) were
obtained from Sigma. The anti-ubiquitin (A-100) antibody
was obtained from Boston Biochem.
Cell Culture and Transfection—Human embryonic kidney
293 (HEK293) cells were cultured in Dulbecco’s modified
Eagle’s medium with Glutamax (Dulbecco’s modified Eagle’s
medium; Invitrogen) supplemented with 10% fetal calf serum
(Invitrogen). The HEK293 cell line stably overexpressing the
-amyloid precursor protein has been described previously
(34). Transfections of cells with PS1 cDNAs were carried out
using FuGENE 6 (Roche) according to the supplier’s instruc-
tions. Pools of stably expressing cells were generated by selec-
tion in 200 g/ml Zeocin (Invitrogen). Cells were treated with
the following compounds for the times indicated in the specific
experiments: MG132 (5 M, Sigma), okadaic acid (1 M,
Sigma), and GSK3 inhibitor VIII (Calbiochem, 10 M, (35)).
Dephosphorylation experiments were carried out with shrimp
alkaline phosphatase as described (32).
Gel Electrophoresis and Western Blotting—Proteins were
separated by SDS-PAGE with the appropriate acrylamide con-
centrations and transferred to nitrocellulose membranes by
Western blotting techniques. Typically 25g of cell extract was
loaded per well for Western immunoblotting. Proteins were
detected using enhanced chemiluminescence techniques (GE
Healthcare).
Immunoprecipitation—Specific proteins were immunopre-
cipitatedwith the respective antibodies, typically with 2–3l of
serum or 1 g of purified antibody. 20 l of protein A-agarose
(Zytomed) was used to bind the IgG over a 2–3-h shaking
period at 4 °C. The bound protein-antibody complex was
washed three times with wash buffer (50 mM Tris/HCl, pH 7.4,
500 mM NaCl, 2 mM EDTA, 0.2% Igepal).
Pull-down Experiments—Purified recombinant proteins
were incubated at a concentration of 1 g/ml (GST or GST--
catenin) and 0.5 g/ml (MBP or MBP-PS1 hydrophilic loop)
with 10l of GSH-Sepharose in 1ml of PBS for 2 h at 4 °C. After
binding, the Sepharose was washed 4 times with PBS. Samples
were subsequently separated by SDS-PAGE and proteins
detected by Western immunoblotting.
Protein Purification—Chromatographywas carried out using
the Äkta FPLC system and appropriate columns from GE
Healthcare. The short versions of the hydrophilic loop were
expressed in E. coli as described above and the cleared homo-
genate was applied to anion exchange chromatography
(ResourceQ column; buffer A, 20 mM Tris/HCl, pH 8.7; buffer
B, 1 M NaCl in buffer A; gradient, 10–35% buffer B over 15
column volumes; flow rate, 6 ml/min). After concentration by
ultrafiltration (Amicon Ultra, Millipore), fusion proteins were
cleaved by treatment with factor Xa according to the suppli-
er’s instructions (New England Biolabs). The hydrophilic
loop was separated from MBP by a second anion exchange
chromatography (ResourceQ column, gradient: 7–28%
buffer B over 25 column volumes, flow rate, 6 ml/min) and
further purified to homogeneity by cation exchange chroma-
tography (MonoS column: buffer A, 20 mM citrate buffer, pH
3.0; buffer B, buffer A with 1 M NaCl, gradient from 40 to 80%
buffer B; flow rate, 1 ml/min).
Gel filtration was carried out using a Superdex 75 10/300
column. Proteins were applied in PBS (running buffer; flow
rate, 0.75 ml/min, 20 g of purified protein) and the elution
monitored by UV absorbance.
In Vitro and in Vivo Phosphorylation of PS1—Phosphoryl-
ation of PS1 in cultured cells was carried out as described
earlier (36). Briefly, a near confluent cell monolayer in a
21-cm2 culture dish was incubated for 45 min in phosphate-
free media (Sigma). The media was aspirated, and phos-
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phate-free media was added, together with 0.125 mCi of
[32P]orthophosphate (Hartmann Analytical, Braunschweig,
Germany). Cells were incubated for 1.5 h at 37 °C. The con-
ditioned media was then aspirated, and cells were washed
twice with ice-cold PBS and immediately lysed on ice with
lysis buffer (see below). Cell lysates were centrifuged for 10
min at 16,000  g, and supernatants were immunoprecipi-
tated with specific anti-PS1 antibodies. Radiolabeled pro-
teins were separated by SDS-PAGE as described above and
detected by autoradiography/phosphorimaging.
In vitro phosphorylation assays with recombinant GSK3
(New England Biolabs) were carried out according to the man-
ufacturer’s instructions. Phosphorylation reactions were
started by addition of 10 M [-32P]ATP and allowed to pro-
ceed for 20 min at 32 °C. Reactions were stopped by the addi-
tion of SDS sample buffer.
Pulse-Chase Experiments—Cells were starved with methio-
nine-free medium for 1 h and subsequently pulsed for 20 min
with [35S]methionine containing medium (100 Ci/21-cm2
dish). After washing the cells with medium containing unla-
beled methionine, cells were chased for the indicated times.
Cells were subsequently fractionated as described below and
proteins were isolated by immunoprecipitation.
Cell Lysis and Fractionation—Cells were scraped off the cul-
ture dish and lysed for 30 min on ice (lysis buffer, 50 mM Tris/
HCl, pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1%
Igepal, Complete protease inhibitor mixture (Roche)). The
lysate was then cleared by centrifugation (16,000  g, 4 °C, 30
min) and the supernatant removed. Protein estimations were
carried out by bicinchoninic acid protein assay (Perbio).
In co-immunoprecipitation experiments cells were lysed in
25 mM HEPES buffer, pH 7.2, containing 100 mM KCl, 100 mM
potassium fluoride, 25 mM -glycerophosphate, 1 mM sodium
orthovanadate, Complete protease inhibitor, and 1% digitonin.
For fractionation, cells were harvested and washed with PBS.
Cells were then resuspended in hypotonic buffer (10 mM Tris/
HCl, pH 7.4, 10 mM NaCl, 0.1 mM EGTA, 25 mM -glycero-
phosphate, 1 mM dithiothreitol and Complete protease inhibi-
tor mixture) and left on ice for 15 min. Cells were then
disrupted by passing the suspension through a 23-gauge syringe
needle for 15 cycles and centrifugation at 200  g for 10 min at
4 °C, the supernatant contained cytosolic and membrane frac-
tion (see below). The pellet, containing the nuclear fraction,
was resuspended inHEPES buffer, pH 7.2, containing 25% glyc-
erol, 400 mMNaCl, 25 mM -glycerophosphate, 1 mM EDTA, 1
mM EGTA, 1 mM dithiothreitol and Complete protease inhibi-
tor and agitated on ice for 20min. The homogenate was centri-
fuged at 16,000  g for 15 min at 4 °C and the supernatant, i.e.
nuclear fraction, collected. Cytosolic and membrane fractions
were separated by centrifugation (16,000 g, 4 °C, 60min). The
supernatant, i.e. cytosolic fraction, was removed and the pellet,
i.e.membrane fraction, was lysed in lysis buffer and centrifuged
(16,000  g, 4 °C, 15 min) to yield a debris-free sample.
Cell Proliferation—Cell proliferation was assessed by meas-
uring themetabolic activity using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide reduction (37). Cells were
seeded at a concentration of 35,000 cells/ml and cultured for
3 days. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide was added to a final concentration of 0.5 mg/ml and
cells were left for 2 h. The precipitated formazan was dissolved
overnight by addition of 10% SDS in 1 mMHCl and the absorb-
ance measured at 570 nm.
Luciferase Reporter Assay—Luciferase reporter assays were
carried out as described (38). Briefly, HEK293 cells were seeded
at 1  105/well in six-well plates, cultured for 24 h, and trans-
fected with 300 ng of the pTOPflash or pFOPflash luciferase
reporter constructs and 500 ng of -catenin plus either PS1wt
or one of the PS1 mutants. A constant amount of DNA was
maintained by the addition of appropriate empty vector plas-
mid. Twenty-four h post-transfection the media was removed
and the cells lysed for 5 min in 300 l of Bright-Glo lysis buffer
(Promega). The lysate was removed, vortexed, and briefly spun
in a microcentrifuge. 150 l of lysate supernatant was then
combined with 150 l of Bright-Glo luciferase assay reagent
(Promega, half-life 30 min) and placed into a 24-well reader
plate. Remaining lysate was used to check transfection efficien-
cies and expression levels byWestern blotting. Luciferase activ-
ity was immediately measured in aWallac 1450Microbeta Tri-
lux luminometer (PerkinElmer Life Sciences).
Data Analysis and Statistics—In metabolic labeling experi-
ments, band intensities were analyzed with a phosphorimager
(Fuji, FLA2000) and the Fuji Image Gauge 3.0 Software. For
enhanced chemiluminescence detection, signals were meas-
ured and analyzed using an ECL imager (ChemiDocTM XRS,
Bio-Rad) and the Quantity One software package (Bio-Rad).
Statistical analysis was carried out using Student’s t test or one-
way analysis of variance with a Newman-Keuls multiple com-
parison post-test (GraphPad Prism, GraphPad Software).
Significance values are as noted in the legends for Figs. 3–6.
RESULTS
GSK3 Phosphorylates the PS1 Hydrophilic Loop at Positions
353 and 357—The hydrophilic loop of PS1 contains two serine
residues at positions 353 and 357 and it has been shown that
synthetic peptides representing amino acids 349–361 can be
phosphorylated by GSK3 in vitro (31) (Fig. 1A). We verified
phosphorylation at these sites using a recombinant hydrophilic
loop domain (aa 263–403) of PS1 and purifiedGSK3 (Fig. 1B).
Mutation analysis showed that mutation of serine residues 353
and 357 to alanine strongly reduced the incorporation of [32P].
A S353A/S357A doublemutation reduced the phosphorylation
evenmore (Fig. 1C), whereasmutations at positions 310, 313, or
324 had little if any effect on GSK3-dependent phosphoryla-
tion (Fig. 1B). However, residual phosphorylation was also
observed in the double mutant, indicating additional phospho-
rylation sites of GSK3.
To determine whether phosphorylation at these sites also
occurred in cultured cells, we stably expressed PS1-wt and the
PS1-S353D/S357D mutant in HEK293 cells and analyzed
[32P]phosphate incorporation. Consistent with previous
results, PS1-wt showed incorporation of [32P] into its C-termi-
nal fragment (CTF-P; Fig. 1D, top panel) (32, 36). In contrast,
phosphorylation of PS1-S353D/S357D was markedly reduced
(Fig. 1D). Notably, the S353D/S357D mutant, which should
mimic phosphorylated PS1 showed very similar migration as
the in vivo phosphorylated CTF of PS1-wt (Fig. 1D, also see Fig.
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2B). The weak phosphorylation of the S353D/S357D mutant is
consistent with additional phosphorylation sites in the PS1
CTF besides Ser353 and Ser357 (15, 31, 32). Cell treatment with a
GSK3 inhibitor decreased the phosphorylation of PS1-wt, but
had little effect on that of PS1-S353D/S357D, indicating an
involvement of GSK3 in the in vivo phosphorylation of PS1 at
Ser353 and Ser357 (Fig. 1D).
Phosphorylation of Ser353 and Ser357 Induces a Structural
Change of the Hydrophilic Loop Domain of PS1—To prove the
different migration behavior of phosphorylated and non-phos-
phorylated PS1 CTF (Fig. 1D), cells were incubated in the pres-
ence or absence of okadaic acidic that inhibits protein dephos-
phorylation by protein phosphatases 1 and 2A. Okadaic acid
treatment resulted in an increase in the slower migrating PS1
CTF (Fig. 2A). Treatment of isolated PS1 CTF with shrimp
alkaline phosphatase reversed this effect, demonstrating that
phosphorylation of the PS1 CTF reduces the migration in SDS
gels (Fig. 2A). As shown in Fig. 1D, CTFs of the PS1-S353D/
S357D mutant showed identical migration as the in vivo phos-
phorylated CTF of PS1-wt. These data indicate that the S353D/
S357D mutant mimics the migration characteristics of
phosphorylated PS1 CTF (Fig. 2B). In contrast, alanine muta-
tions at these sites increased themigration of the PS1 CTF (Fig.
2B). Next, we analyzed the migration of recombinant purified
loop domains of PS1-wt and the S353D/S357D mutant. As
observed for the cellular PS1 CTFs, the purified loop domain of
the S353D/S357D mutant showed slower migration as com-
pared with the wt protein (Fig. 2C). To address the question
whether this change in migration is due to a structural change
or merely a difference in the charge, we analyzed migration in
SDS gels with increasing concentrations of urea. Whereas the
PS1-wt hydrophilic loop did not change its migration, the PS1-
S353D/S357D mutant showed urea concentration dependent
mobility (Fig. 2D). At 4Murea, themutant co-migratedwith the
wt loop, indicating that denaturation abolished themigrational
differences. We also analyzed the retention of wt and S353D/
S357Dmutant loop by size exclusion chromatography (Fig. 2E).
Here, the PS1-S353D/S357Dmutant loop (middle panel) had a
reduced retention time compared with the wild-type loop (top
panel). The two different variants of the hydrophilic loop could
still be separated when a mixture was applied to the column
(bottompanel). Because themolecularmasses of the twohydro-
philic loops only differ by 56 Da, these results also indicate a
structural difference between wt and phosphomimicking
mutant. This is reflected by differences in the calculated Stokes
radii of 2.4 and 2.9 nm for the wt and S353D/S357D mutant,
respectively. Together, these data indicate that phosphoryla-
tion of PS1 CTF induced a structural change of the hydrophilic
loop domain that can be mimicked by the S353D/S357D
mutant.
Phosphorylation of the PS1 Hydrophilic Loop Decreases the
Interaction with -Catenin—-Catenin has been shown to
interact with PS1 (18, 39). However, others have suggested that
PS1 does not bind directly to-catenin (40). To analyze a direct
interaction, we performed pull-down assays with recombinant
purified fusion proteins. A fusion protein consisting of the
MBP-PS1-hydrophilic loop (aa 298–380) could be pulled down
by GST--catenin (aa 134–668), demonstrating a direct inter-
action of both proteins (Fig. 3A). To investigate whether the
phosphorylation of PS1 CTF reduces the interaction with
-catenin in cultured cells, we carried out co-immunoprecipi-
tation experiments. Precipitation of -catenin with anti--
catenin antibodies led to co-precipitation of the PS1 CTF (Fig.
3B, first and second lanes). However, the signal was strongly
reduced compared with a co-precipitation with an antibody
directed against the N terminus of PS1 (PS1 NTF; Fig. 3B, third
and fourth lanes), indicating that only a fraction of -catenin is
bound to PS1 CTF. Interestingly, -catenin preferentially co-
precipitated the non-phosphorylated, lower migrating form of
PS1 CTF (Fig. 3, B andC). As compared with precipitation with
the PS1 NTF antibody, co-precipitation of the phosphorylated
PS1 CTF with a -catenin antibody was reduced by about 40%
FIGURE 1. Phosphorylation of presenilin 1 hydrophilic loop by GSK3.
A, sequence of PS1 adjacent to amino acid residues 353 and 357. The
sequence contains the recognition motif for GSK3: (S,T)XXX(S,T). B and
C, recombinant PS1 hydrophilic loop domains (PS1 HL) are phosphorylated in
vitro by GSK3. The domains that harbor phosphorylation site mutations as
indicated. Upper panels, autoradiograph of 32P-labeled hydrophilic loop
mutants (32P). Lower panels, Western immunoblotting (WB) using APS18 anti-
body (B) or Coomassie Brilliant Blue (CBB) stain (C) as loading control. D, in vivo
phosphorylation of PS1 CTFs. HEK293 cells stably expressing PS1-wt or PS1-
S353/357D mutant were labeled with [32P]orthophosphate for 11⁄2 h in the
presence or absence of GSK3 inhibitor VIII (Calbiochem). PS1 CTFs were
immunoprecipitated with antibody 3109 and Western blotted. Incorporated
[32P]phosphate was detected by phosphorimaging (32P). Subsequently, total
PS1 CTFs were detected by probing the membrane with the APS18 antibody
(WB). Phosphorylated PS1 CTFs (CTF-P) showed reduced mobility compared
with not phosphorylated PS1 CTFs (CTF). One representative experiment is
shown.
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(Fig. 3, B and C). Similar results were obtained from co-precip-
itation studies with endogenous PS1 (data not shown).We also
carried out co-immunoprecipitation experiments from total
cell lysates of HEK293 cells expressing wt ormutant PS1 (Fig. 3,
D and E). The amount of co-immunoprecipitated -catenin
was significantly reduced with the PS1-S353D/S357D mutant,
as compared with PS1-wt (Fig. 3, D and E). Notably, PS1-
S353A/S357A, which also shows a structural change (see Fig.
2B), also reduced the interaction with -catenin. These results
indicate that Ser353 and Ser357 are critical for the conformation
dependent interaction of PS1 and -catenin. Because the
S353A/S357Amutant also decreases this interaction, this variant
couldnotbeused tomimicanon-phosphorylated formofPS1.For
further functional analysis of PS1 phosphorylation, we therefore
compared the PS1-S353D/S357Dmutant with PS1-wt.
Phosphorylation of PS1 Hydrophilic Loop Decreases the
Phosphorylation and Ubiquitination of -Catenin—PS1
facilitates -catenin degradation in cells by coupling the
paired phosphorylation of -catenin (25). Because the phos-
phorylation of PS1 at serine residues 353 and 357 reduces
-catenin binding, we analyzed the phosphorylation and
ubiquitination of -catenin in cells expressing PS1-wt or
-S353D/S357D. In cytosolic fractions of PS1-wt expressing
cells, two -catenin bands were detected. Whereas the lower
band corresponds to the recorded molecular mass of 94 kDa
(Fig. 4A), the upper band (-catenin* in Fig. 4A) migrates at
FIGURE 2. Phosphorylation of PS1 hydrophilic loop induces a structural change. A, HEK293 cells stably expressing PS1-wt were incubated in the presence
() or absence () of okadaic acid (OA). PS1 was immunoprecipitated and treated with () or without () shrimp alkaline phosphatase (SAP) and detected by
Western immunoblotting with APS18 antibody. B, detection of different PS1 CTFs by Western immunoblotting. Mutations are indicated: control, non-trans-
fected (endogenous PS1-wt CTF). C, Coomassie Brilliant Blue stain of purified recombinant PS1 hydrophilic loop (PS1 HL, aa 298 –380) separated on 15%
SDS-PAGE. D, urea abolishes migration differences between PS1-S353D/S357D and PS1-wt hydrophilic loops. Purified MBP-PS1 hydrophilic loop fusion
proteins (5 g) were cleaved by factor Xa and separated by SDS-PAGE at the indicated urea concentrations. Whereas the migration of the PS1 hydrophilic loop
domains (PS1 HL) was changed by urea, MBP did not show a changed migration. E, gel filtration of purified recombinant PS1-wt (20 g, wt in upper panel) and
PS1-S353/357D (20 g, S353/357D in middle panel) hydrophilic loop domains on a Sephadex 75 size exclusion column. Note that both proteins could still be
separated when applied together (lower panel, S353D/S357D and wt profiles are shown as overlays).
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about 105 kDa. As compared with PS1-wt cells, PS1-S353D/
S357Dmutant cells revealed less cytosolic -catenin migrat-
ing at a higher molecular weight, whereas the lower migrat-
ing form was slightly increased (Fig. 4A). The relative
amount of the upper band changed from 50% of total cyto-
solic -catenin in PS1-wt to 30% in PS1-S353D/S357D
expressing cells (Fig. 4B).
To characterize the different -catenin variants in more
detail, we immunoprecipitated -catenin from the cytosolic
fraction of cells treated with MG132. As described in Fig. 4A,
the pan--catenin antibody detects two bands of about 94 and
105 kDa (Fig. 4C, lanes 1 and 2). A phosphorylation state-spe-
cific antibody, which selectively recognizes-catenin phospho-
rylated at Ser33/Ser37, detected a main band with an apparent
molecular mass of 105 kDa but not the 94-kDa form (Fig. 4C,
third and fourth lanes). The upper band was also detected by an
anti-ubiquitin antibody (Fig. 4C, fifth and sixth lanes). Further-
more, samples run on low percentage SDS gels showed ladder-
ing and a smear typical for polyubiquitinated proteins (Fig. 4D,
first and second lanes). Indeed, probing with an anti-ubiquitin
antibody indicated ubiquitination of the higher migrating
-catenin variants (Fig. 4D, third and fourth lanes), indicating
that the higher migrating bands represent phosphorylated
and/or ubiquitinated -catenin. Further analysis showed that
these variants are significantly reduced in the cytosolic and
membrane fractions by about 25 and 20%, respectively, in PS1-
S353D/S357D compared with PS1-wt expressing cells (Fig. 4, E
and F). Together, these data indicate that phosphorylation of
PS1 reduced phosphorylation and ubiquitination of -catenin.
Phosphorylation of PS1 Hydrophilic Loop Increased
Nuclear Levels of -Catenin—To analyze the time-depend-
ent phosphorylation/ubiquitination of -catenin, we per-
formed pulse-chase experiments with cells expressing
PS1-wt or PS1-S353D/S357D. After pulse labeling, -cate-
nin was immunoprecipitated from isolated membranes and
analyzed by phosphorimaging. The major 94-kDa form of
-catenin was almost unchanged over a 3-h period (Fig. 5A). In
PS1-wt expressing cells, a time dependent increase of the 105-
FIGURE 3. Phosphorylation of PS1 hydrophilic loop reduces binding to -catenin. A, pull-down of PS1 hydrophilic loop by -catenin. Purified fusion
proteins GST--catenin (0.5 g, aa 134 – 668) and MBP-PS1-wt (1 g, aa 298 –380) were incubated and precipitated with GSH-Sepharose (see “Experimental
Procedures”). Specific fusion proteins were detected by Western immunoblotting with anti-MBP antibodies (3109, raised against MBP-PS1-HL) or anti-GST
antibodies (2972, raised against GST-PS2-NTF). B, co-immunoprecipitation of PS1 by -catenin. HEK293 cells stably expressing PS1-wt were lysed and PS1 was
precipitated by anti--catenin (-catenin), anti-PS1-NTF (PS1-NTF), or preimmune serum (PI). Co-precipitated PS1-CTF was analyzed by Western immunoblot-
ting with APS18 (top panel). -Catenin was detected as a control (bottom panel). C, quantification of co-immunoprecipitation experiments and statistical
analysis by t test (n  3). D, co-immunoprecipitation of -catenin from total cell lysate by PS1. HEK293 cells stably expressing PS1-wt, -S353D/S357D or
-S353A/S357A were lysed and PS1 was immunoprecipitated by APS18 antibody. Co-precipitated -catenin was analyzed by Western immunoblotting.
E, quantification of co-immunoprecipitation experiments and statistical analysis by analysis of variance (n  4). Significance values are as follows: *, p 
0.05; **, p  0.01; ***, p  0.001.
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kDa -catenin was observed, indicating phosphorylation
and/or ubiquitination (Fig. 5, A and B). This conversion was
strongly decreased in PS1-S353D/S357D expressing cells (Fig.
5, A and B). As in PS1-wt expressing cells, the membrane-asso-
ciated pool of -catenin was stable over the 3-h chase period.
Interestingly, significant differences were observed after a 6-h
chase. About 60% of -catenin was turned over in PS1-wt
expressing cells (Fig. 5,C andD). In contrast, very little decrease
of membrane-associated -catenin was detected in PS1-
S353D/S357D expressing cells (20%, Fig. 5, C and D). These
data indicate that phosphorylated PS1 decreased the phospho-
rylation and degradation of the membrane-associated pool of
-catenin. In contrast to the slow turnover of membrane-asso-
ciated -catenin, cytosolic -catenin was efficiently turned
over after 6 h (Fig. 5, E and F). However, cytosolic levels of
-cateninwere higher in PS1-S353D/S357D (10%) as compared
with PS1-wt expressing cells (6%, Fig. 5, E and F). In further
experiments, cells stably expressing wt or mutant PS1 were
treated with cycloheximide that inhibits protein de novo
synthesis. In PS1-wt expressing cells, cytosolic -catenin was
turned over rapidly (t1⁄2  24 min), whereas in cells expressing
the PS1-S353D/S357D mutant the turnover of -catenin was
prolonged (t1⁄2  65 min) (data not shown).
Stabilized cytosolic -catenin could translocate to the
nucleus and mediate transcription of target genes. Consistent
with stabilization of the membrane-associated and the cytoso-
lic pool of -catenin, we also observed increased levels of
-catenin in the nuclear fraction of PS1-S353D/S357D as com-
pared with PS1-wt expressing cells (Fig. 5, G and H).
Phosphorylation of the PS1 Hydrophilic Loop Negatively
Modulates Signaling of -Catenin—To determine whether the
increase of -catenin in the nucleus has an effect on signaling
activity via the Tcf/Lef transcription pathway, TOPflash
reporter assays were carried out. As compared with non-trans-
fected cells, expression of PS1-wt reduced the reporter signal,
which is consistentwith previous studies (29, 38). Notably, PS1-
FIGURE 4. PS1 phosphorylation reduces -catenin degradation. A, cytosolic -catenin levels in PS1-wt and PS1-S353D/S357D mutant cells. Cytosolic
fractions (see “Experimental Procedures”) were analyzed by Western immunoblotting using an anti--catenin antibody (C2206). -Catenin* represents a high
molecular weight species of -catenin. B, quantification of cytosolic -catenin* levels in A as the percentage of total -catenin. Statistical analysis was carried
out using a Student’s t test (n  3). C, characterization of the observed -catenin isoforms. HEK293 cells stably expressing PS1-wt were treated with 10 M
MG132 for 16 h and -catenin was immunoprecipitation from the cytosolic fraction with an anti--catenin antibody (C2206). The specific isoforms were
detected by anti--catenin (C2206), anti-pSer33,37--catenin (C4231), and an anti-ubiquitin antibody (A-100) as indicated. Each detection was carried out in
duplicate. D, stabilization of -catenin in HEK293 cells stably expressing PS1-wt. Cells were treated with 5 M MG132 for 16 h. Cytosolic fractions were isolated,
-catenin immunoprecipitated, and analyzed by Western immunoblotting with an anti--catenin (C2206) or anti-ubiquitin antibody (A-100). Duplicate
samples are shown. E, cytosolic and membrane pSer33,37--catenin in PS1-wt and PS1-S353D/S357D mutant cells were analyzed by Western immunoblotting
using an anti-pSer33,37--catenin (C4231) antibody. F, quantification of cytosolic pSer33,37--catenin levels, statistical analysis was carried out using a Student’s
t test (n  4). Significance values are as follows: *, p  0.05; **, p  0.01.
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S353D/S357D did not significantly reduce the reporter signal
(Fig. 6A). Very similar data were also obtained when cell signal-
ing was stimulated by transfection with -catenin (Fig. 6B).
Because c-MYC is a known target gene of the Tcf/Lef tran-
scription pathway (41, 42), we next analyzed its expression in
PS1-wt and PS1-S353/357D mutant expressing cells. Whereas
expression of PS1-wt decreased the cellular levels of c-myc as
compared with non-transfected cells, this reduction was much
less pronounced by expression of PS1-S353D/S357D (Fig. 6C).
Consistent with decreased expression of c-myc, cells overex-
pressing PS1-wt showed decreased proliferation as compared
with non-transfected cells (Fig. 6D). Cells overexpressing PS1-
S353D/S357D showed intermediate proliferation rates, indi-
cating a reduced ability to regulate cell proliferation.
DISCUSSION
PS1 has been shown to bind -catenin (18, 20, 39) and facil-
itate its degradation and therefore serves a function compara-
FIGURE 5. PS1 phosphorylation decreases -catenin turnover. A, short term pulse-chase of -catenin. Cells expressing PS1-wt or PS1-S353D/S357D were
starved with methionine-free medium for 60 min and pulsed with [35S]methionine containing medium for 20 min. After replacing the medium with unlabeled
methionine, cells were chased for the indicated times. Membrane fractions were prepared, lysed, and -catenin immunoprecipitated (C2206). Labeled
-catenin was analyzed by Western blotting and subsequent phosphorimaging. The generation of the high molecular weight species of -catenin (-catenin*)
as a fraction of total -catenin at the start of the chase is depicted in B (n  2). C–F, long term pulse-chase of -catenin. Same procedures as described in A for
longer chase times. Cytosolic (C) and membrane (E) fractions were prepared, lysed, and -catenin immunoprecipitated (C2206). Labeled -catenin was
analyzed by Western blotting and subsequent phosphorimaging. D and F, quantification of total -catenin as the percentage of -catenin at the beginning of
the chase (t  0, n  3). G, -catenin translocation into the nucleus. HEK293 cells stably expressing PS1-wt or PS1-S353D/S357D were subjected to cell
fractionation and the nuclear fraction was analyzed by Western immunoblotting (C2206). The high molecular weight form observed (-catenin**) could
represent a phosphorylated -catenin described recently (47, 48). H, quantification of -catenin as the ratio of nuclear -catenin to total -catenin, normalized
to PS-1wt cells. Statistical analysis were carried out using a Student’s t test (n  5). Significance values are as follows: ns, not significant; *, p  0.05; ***, p  0.001.
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ble with the adenomatous polyposis coli-axin scaffolding com-
plex involved in theWnt signaling pathway (25). It has also been
shown thatGSK3 could phosphorylate synthetic peptides rep-
resenting a PS1 sequence that contains Ser353 and Ser357 (31),
and that GSK3 is associated with PS1/-catenin to form a
ternary complex (43). We now show that the phosphorylation
of PS1 by GSK3 at serines 353 and 357, which are highly con-
served in PS1 of different mammalian species (31, 32), has sig-
nificant effects on the structure of the large hydrophilic loop
domain of the PS1 CTF, as indicated by reduced mobility in
SDS-PAGE and retention in gel filtration experiments. The
structural change of PS1 induced by phosphorylation could be
mimicked by a PS1-S353D/S357D double mutation that
allowed the functional analysis in cultured cells without the
need for pharmacological manipulation with protein kinase
and phosphatasemodulators. Of note, the S353D/S357Dmuta-
tion did not inhibit the endoproteolytic processing of PS1 and
exerts normal -secretase activity as indicated by unaltered
production of A (data not shown).
The hydrophilic loop domain could interact with -catenin
(39). However, Serban et al. (40) suggested a ternary complex of
-catenin, PS1, and E-cadherin in which E-cadherin is essential
for the binding of PS1 and -catenin. As shown here, purified
recombinant fusion proteins of the PS1 hydrophilic loop and
-catenin bind directly in the absence of E-cadherin. However,
the interaction of PS1 and -catenin might be modulated by
E-cadherin. The functional investigation of PS1 phosphoryla-
tion in cultured cells revealed that it negatively regulates the
interaction with -catenin by changing the structure of its
hydrophilic loop domain.
Pulse-chase experiments revealed that phosphorylation of
PS1 reduces the phosphorylation and ubiquitination of mem-
brane-associated -catenin, resulting in its stabilization.More-
over, we also observed stabilization of the cytosolic -catenin
pool. This is in accordance to findings where cells expressing a
PS1 variant lacking the -catenin binding site but exerting
-secretase activity show decreased turnover of -catenin (29,
30). How could the phosphorylation of membrane-tethered
PS1 affect cytosolic -catenin levels? The decreased binding of
-catenin to phosphorylated PS1 could uncouple the paired
phosphorylation of -catenin and thereby decrease the turn-
over of membrane-associated -catenin. The stabilized -cate-
nin could dissociate from the membrane leading to increased
levels of-catenin in the cytosolic and nuclear fraction. Indeed,
we observed increased cytosolic and nuclear pools of -catenin
at steady state, whereas the membrane-associated pool was not
significantly increased (not shown). In addition, PS1might also
affect the metabolism of cytosolic -catenin indirectly by reg-
ulating the levels of GSK3 in the cytosol or other signal trans-
duction pathways (see also Ref. 38).
Cells expressing PS1-S353D/S357D showed increased tran-
scription of the TOPflash promoter compared with cells
expressing PS1-wt. In addition, PS1-S353D/S357D expressing
cells revealed higher levels of endogenous c-myc, and increased
FIGURE 6. PS1 phosphorylation positively modulates -catenin signal-
ing. A, TOPflash reporter assays were carried out with HEK293 cells transiently
transfected with PS1-wt, PS1-S353D/S357D, or non-transfected (n.t.). B, as A
with co-transfection of -catenin. Values represent fold-stimulation over
non-transfected cells (n.t.  1, not shown). C, detection of c-myc and -actin
in stably transfected HEK293 cells by Western immunoblotting. D, 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide proliferation assay of
stably transfected HEK293 cells. Statistical analyses were carried out by
analysis of variance (n  3 (A and B), n  16 (D)). Significance values are as
follows: ns, not significant; *, p  0.05; **, p  0.01; ***, p  0.001.
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cell proliferation as compared with cells expressing PS1-wt.
Together, these data indicate that the metabolism of -catenin
and its nuclear signaling can be regulated by phosphorylation-
dependent binding to PS1. In accordance with our findings,
PS1-deficient fibroblasts show increased CYCLIN D1 expres-
sion and cell proliferation (29). Moreover, mice that only
express PS1 in neurons develop skin tumors (30). The lack or
loss of function of PS1 may therefore lead to aberrant cell pro-
liferation and tumorigenesis. However, -catenin signaling in
development and tumorigenesis might be mainly regulated via
the Wnt/adenomatous polyposis coli/Axin pathway (27, 28)
and further studies are necessary to elucidate the contribution
of PS1-phosphorylation dependent regulation of -catenin
metabolism in these processes.
Moreover, PS1 could affect -catenin signaling by an addi-
tional mechanism. Because PS1 is the proteolytic active com-
ponent of the-secretase complex, the cleavage of its substrates
N- and E-cadherin can also liberate -catenin from cellular
membranes (12, 13, 44). It has also been shown recently that
ADAM10 induced shedding of N-cadherin increased c-MYC,
c-JUN, and CYCLIN D1 expression, likely by subsequent cleav-
age of N-cadherin and liberation of -catenin from the mem-
brane (12). Thus PS1 might exert a dual function in -catenin
regulation, either by direct association with -catenin via the
hydrophilic loop domain and facilitation of-catenin phospho-
rylation, or by cleaving cadherins and liberation of bound
-catenin from the membrane.
Recently, the role of Wnt signaling and -catenin in the reg-
ulation of synaptic differentiation and organization has been
highlighted(45,46).BecausePS1isrecruitedtocadherin/catenin-
dependent cell-cell adhesion contacts in synapses (10), the reg-
ulation and modulation of synaptic function and plasticity via
the proteolytic activity of -secretase has been proposed (10,
44). In addition, GSK3-mediated phosphorylation of PS1
could modulate synapse function via -catenin in a -secretase
independent manner.
The following model is consistent with the observed PS1
phosphorylation state-dependent metabolism and signaling of
-catenin (Fig. 7). -Catenin and GSK3 are recruited to the
non-phosphorylated hydrophilic loop domain of PS1. This ter-
nary complex allows efficient phosphorylation of -catenin by
GSK3 and subsequent release into the cytoplasm where it
undergoes ubiquitination and degradation. Dissociation of
-catenin then allows phosphorylation of PS1 byGSK3, which
induces a structural change that inhibits further binding of
-catenin. Thus, phosphorylation of PS1 would be an efficient
switch-off mechanism of PS1-dependent degradation of
-catenin. To test this model, further research could focus on
the time-dependent association and dissociation as well as the
coordinated phosphorylation of PS1 and -catenin by GSK3
at cellular membranes.
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